ARTICLE |
a Greenwood Genetic Center, Greenwood, South Carolina
b Department of Pediatrics, Rhode Island Hospital, Providence, Rhode Island
c Department of General Pediatrics, Childrens Hospital, Boston, Massachusetts
d Medical University of South Carolina, Charleston, South Carolina
e College of Medicine, University of Florida, Gainesville, Florida
f Marshfield Clinic, Medical Genetic Services, Marshfield, Wisconsin
OBJECTIVE. Our goal was to describe the neurologic and clinical features of affected males from families with X-linked patterns of severe mental retardation, hypotonia, recurrent respiratory infection, and microduplication of Xq28 that consistently includes the MECP2 (methyl-CpG binding protein 2) gene.
STUDY DESIGN. To identify duplications, multiplex ligation-dependent probe amplification of the MECP2 gene was performed on male probands from families with X-linked mental retardation. The males either had linkage to Xq28 or had a phenotype consistent with previous reports involving Xq28 functional disomy. After detection of a duplication of MECP2, additional family members were tested to confirm the MECP2 duplication segregated with the affected phenotype, and X-inactivation studies were performed on carrier females.
RESULTS. Six families with multiple affected males having MECP2 duplications were identified by multiplex ligation-dependent probe amplification, and the carrier mothers were subsequently shown to have highly skewed X inactivation. In 5 of 6 families, the microduplication extended proximally to include the L1 cell adhesion molecule gene. The primary clinical features associated with this microduplication are infantile hypotonia, recurrent respiratory infection, severe mental retardation, absence of speech development, seizures, and spasticity.
CONCLUSIONS. Although many of the phenotypic features of our patients are rather nonspecific in cohorts of individuals with syndromic and nonsyndromic mental retardation, the proneness to infection is quite striking because the patients had normal growth and were not physically debilitated. Although the etiology of the infections is not understood, we recommend considering MECP2 dosage studies and a genetics referral in individuals with severe developmental delay and neurologic findings, especially when a history of recurrent respiratory ailments has been documented.
Key Words: mental retardation hypotonia recurrent infection MECP2 duplication
Abbreviations: MECP2methyl-CpG binding protein 2 gene XLMRX-linked mental retardation L1CAML1 cell adhesion molecule gene MLPAmultiplex ligation-dependent probe amplification PCRpolymerase chain reaction Igimmunoglobulin ANAantinuclear antibody CFcystic fibrosis
This article has been cited by other articles:
![]() |
R. C. Samaco, J. D. Fryer, J. Ren, S. Fyffe, H.-T. Chao, Y. Sun, J. J. Greer, H. Y. Zoghbi, and J. L. Neul A partial loss of function allele of Methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome Hum. Mol. Genet., June 15, 2008; 17(12): 1718 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bauters, H. Van Esch, M. J. Friez, O. Boespflug-Tanguy, M. Zenker, A. M. Vianna-Morgante, C. Rosenberg, J. Ignatius, M. Raynaud, K. Hollanders, et al. Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair Genome Res., June 1, 2008; 18(6): 847 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Percy Rett Syndrome: Recent Research Progress J Child Neurol, May 1, 2008; 23(5): 543 - 549. [Abstract] [PDF] |
||||
![]() |
L. Villard MECP2 mutations in males J. Med. Genet., July 1, 2007; 44(7): 417 - 423. [Abstract] [Full Text] [PDF] |
||||